… literature that examined the cost-effectiveness of 9vHPV vaccination were included in this
systematic review… A wide type of study perspectives including societal and health systems …

… Fifteen years following the approval of the first human papillomavirus (HPV) vaccine, cervical
cancer continues to be a significant source … was cost effective with an ICER of $79,022/LYS …

… to distribute resources in a more efficient manner. The aim of the present systematic review
was to synthesize the evidence on cost-effectiveness of HPV vaccination in Latin America, to …

… systematic reviews in which researchers evaluated outcomes related to the safety, efficacy,
and effectiveness of HPV vaccines. … systematic reviews that studied any type of HPV vaccine. …

… The impact of human papillomavirus vaccination in the United States: insights from comparing
mathematical model predictions and surveillance data. Presented at 32nd International …

… . The ethics of implementing human papillomavirus vaccination in developed countries.
Med Health Care Philos 2011;14:19–27.doi:10.1007/s11019-010-9285-9 pmid:http://www.ncbi.…

… A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women
and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for …

… analysis (US$2.28-$3.42 per dose) with minimal effect on our … a systematic review of
cost-effectiveness of HPV vaccination in … costs can constitute as much as 40% of the total cost per …

… meta-regression analysis of published CEAs of human papillomavirus (HPV) vaccination to
… -level, and predict incremental cost-effectiveness ratios (ICERs) for HPV vaccination in 195 …

… systematic review, we identified 21 observational studies that evaluated HPV vaccine
effectiveness against different HPV-related disease outcomes by age at which the vaccine series …